Skip To Main Content
Instituto Toscano Tumori on Muck Rack

Instituto Toscano Tumori

As seen in: Annals of Oncology, Cancer Treatment Reviews
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Instituto Toscano

Contact Instituto Toscano, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Adherence to Oral Cancer Therapy in Older Adults: The International Society of Geriatric Oncology (SIOG) Taskforce Recommendations

|
By Instituto Toscano Tumori, Anna Rachelle Mislang, Nuovo Ospedale-Santo Stefano, Tanya M. Wildes
| Cancer Treatment Reviews Verified
Publication HistoryPublished online: May 15, 2017Accepted: May 6, 2017; Received in revised form: May 5, 2017; Received: April 1, 2017;
Open in Who Shared Issue with article?

Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small-cell lung cancer: treating the right patients based on individualized treatment effect prediction

|
By L. Boni, Instituto Toscano Tumori, A. Ardizzoni, E. F. Smit
| Annals of Oncology Verified
↵ † Prior presentations: Preliminary results of this study have been presented during the poster display session on the European Society for Medical Oncology 2014 Congress in Madrid, Spain on 27 September 2014. Background Translating results from randomized clinical trials (RCTs) to individual patients in clinical practice is challenging, as treatment effects can vary substantially among individuals.
Open in Who Shared Issue with article?

Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small cell lung cancer: treating the right patients based on individualized treatment effect prediction

|
By R. C. M. van Kruijsdijk, F. L. J. Visseren, L. Boni, Instituto Toscano Tumori, H. J. M. Groen
| Annals of Oncology Verified
Background Translating results from randomized clinical trials (RCTs) to individual patients in clinical practice is challenging, as treatment effects can vary substantially among individuals. Data from RCTs can be used for individualized treatment effect prediction, to identify patients who benefit from specific treatments.
Open in Who Shared Issue with article?
See all 3 articles